Our long-term research on the biological significance of genomic sequences that readily adopt non-B DNA structures led us to discover a specialized sequence context in which DNA bases readily becomes unpaired under superhelical strain. We called sequences with such unusual physical properties base unpairing regions (BURs). We subsequently identified SATB1, a nuclear protein that recognizes and specifically binds in vivo to BUR DNA. During the last funding period, we uncovered a new dimension in mammalian gene regulation in which SATB1 folds chromatin into loops and simultaneously regulates a large number of genes. BURs of target gene loci are tethered onto the SATB1 protein network, which serves as an architectural platform to recruit transcriptional regulators and chromatin remodeling proteins to alter epigenetic states at target loci. Interestingly, we have observed such "genome organizing" activity to be closely associated with dramatic cellular changes, such as during T cell development, T cell activation, and acquisition of aggressive cancer phenotypes. Our next goals are proposed in four aims: 1) determine the roles of Satb1 post-translational modifications on functional chromatin organization and tumorigenesis, 2) determine genome organization underlying aggressive cancer, 3) study the biological function of mobile versus immobile SATB1 populations, and 4) identify and investigate the role of novel BUR-binding proteins in ES cells. These studies, connecting nuclear architecture and chromatin dynamics, will provide a new concept in gene regulation that underlies major changes in cellular phenotypes, such as during cancer progression and cell development.
Recent findings suggest that during cellular changes, as when stem cells differentiate or cancer cells become metastatic, global changes in gene expression occur. Such a complex, large-scale event requires proper packaging and organization of the genomic DNA. Proteins that direct this organization, therefore, play key roles in many different biological processes. We will study how these proteins function to fold DNA and coordinate proper gene expression in mammalian nuclei, identify new proteins with these functions, and investigate their roles in stem cells and cancer progression.
|Satoh, Yusuke; Yokota, Takafumi; Sudo, Takao et al. (2013) The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity 38:1105-15|
|Kohwi-Shigematsu, Terumi; Poterlowicz, Krzysztof; Ordinario, Ellen et al. (2013) Genome organizing function of SATB1 in tumor progression. Semin Cancer Biol 23:72-9|
|Balamotis, Michael A; Tamberg, Nele; Woo, Young Jae et al. (2012) Satb1 ablation alters temporal expression of immediate early genes and reduces dendritic spine density during postnatal brain development. Mol Cell Biol 32:333-47|
|Fessing, Michael Y; Mardaryev, Andrei N; Gdula, Michal R et al. (2011) p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol 194:825-39|
|Russo, Jose; Han, Hye-Jung; Kohwi, Yoshinori et al. (2008) New advances in breast cancer metastasis. Womens Health (Lond Engl) 4:547-9|
|Nakayama, Yuji; Mian, I Saira; Kohwi-Shigematsu, Terumi et al. (2005) A nuclear targeting determinant for SATB1, a genome organizer in the T cell lineage. Cell Cycle 4:1099-106|
|Grishina, Irina; Lattes, Bradford (2005) A novel Cdk2 interactor is phosphorylated by Cdc7 and associates with components of the replication complexes. Cell Cycle 4:1120-6|
|Kieffer, Lynda J; Greally, John M; Landres, Inna et al. (2002) Identification of a candidate regulatory region in the human CD8 gene complex by colocalization of DNase I hypersensitive sites and matrix attachment regions which bind SATB1 and GATA-3. J Immunol 168:3915-22|
|Ramakrishnan, M; Liu, W M; DiCroce, P A et al. (2000) Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2. Mol Cell Biol 20:868-77|
|Hsu, H L; Gilley, D; Galande, S A et al. (2000) Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev 14:2807-12|
Showing the most recent 10 out of 12 publications